Citalopram Hydrobromide
Product Images NDC 70934-127

4 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Citalopram Hydrobromide (NDC 70934-127). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (6ead67b1 Fded 47fc Bdee 45be43fd96e9 01)

Image (6ead67b1 Fded 47fc Bdee 45be43fd96e9 01)
Chemical structure of Citalopram Hydrobromide, showing the molecular arrangement including a fluorophenyl group, nitrile group, and a dimethylaminoethyl side chain with a hydrobromide (HBr) moiety.*
FDA Label Image

Logo (6ead67b1 Fded 47fc Bdee 45be43fd96e9 02)

FDA Label Image

Logo (6ead67b1 Fded 47fc Bdee 45be43fd96e9 03)

FDA Label Image

70934 127 30 Master Bottle Label Approval Rev B 10 19

70934 127 30 Master Bottle Label Approval   Rev B 10 19
Citalopram Hydrobromide Tablets, USP 20 mg, packaged in a 30-tablet blister pack by Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The label includes storage instructions, dosage warnings, and multiple individual tablet safety peel-off labels with NDC and other lot information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.